Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
Q1 2026 earnings • in 3 days
See details
SDZ:SWX
Sandoz Group AG
CHF 63.32
-1.86%
(-1.20) 1D
Apr 24, 5:30:01 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for SDZ...
Open
CHF 64.42
High
CHF 64.42
Low
CHF 62.76
Mkt. cap
27.90B
Avg. vol.
814.78K
Volume
449.84K
Dividend
1.26%
Quarterly dividend
CHF 0.20
Ex dividend date
Apr 13, 2026
P/E ratio
38.56
52-wk high
CHF 72.70
52-wk low
CHF 31.72
EPS
CHF 1.64
Shares outstanding
440.00M
No. of employees
22K
News stories
From sources across the web
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG
CEORichard Saynor
Employees22.4K
Founded1886
Headquarters-
SectorPharmaceutical industry
Websitesandoz.com
Next call in 3 days
Wed, Apr 29, 1:00 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ -USD
Revenue / Estimate
-/ (2.76B est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.63B
2.63B
2.95B
2.95B
Cost of goods sold
1.43B
1.43B
1.50B
1.50B
Cost of revenue
1.43B
1.43B
1.50B
1.50B
Research and development expenses
252.00M
252.00M
272.00M
272.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
596.00M
596.00M
668.50M
668.50M
Operating expense
904.50M
904.50M
1.02B
1.02B
Total operating expenses
2.33B
2.33B
2.52B
2.52B
Operating income
301.00M
301.00M
421.50M
421.50M
Other non operating income
6.50M
6.50M
-28.00M
-28.00M
EBT including unusual items
252.00M
252.00M
351.50M
351.50M
EBT excluding unusual items
252.00M
252.00M
367.50M
367.50M
Income tax expense
63.50M
63.50M
83.00M
83.00M
Effective tax rate
25.20%
25.20%
23.61%
23.61%
Other operating expenses
56.50M
56.50M
82.50M
82.50M
Net income
188.50M
188.50M
268.50M
268.50M
Net profit margin
7.16%
7.16%
9.11%
9.11%
Earnings per share
-
-
-
-
Interest and investment income
-
-
23.50M
23.50M
Interest expense
-55.50M
-55.50M
-54.50M
-54.50M
Net interest expenses
-55.50M
-55.50M
-31.00M
-31.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
415.00M
415.00M
531.00M
531.00M
Gain or loss from assets sale
-8.00M
-8.00M
-3.00M
-3.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer